These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 25748122)

  • 1. New functionalized mercaptoundecahydrododecaborate derivatives for potential application in boron neutron capture therapy: synthesis, characterization and dynamic visualization in cells.
    Genady AR; Ioppolo JA; Azaam MM; El-Zaria ME
    Eur J Med Chem; 2015 Mar; 93():574-83. PubMed ID: 25748122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New strategy for synthesis of mercaptoundecahydrododecaborate derivatives via click chemistry: possible boron carriers and visualization in cells for neutron capture therapy.
    El-Zaria ME; Nakamura H
    Inorg Chem; 2009 Dec; 48(24):11896-902. PubMed ID: 19928788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide.
    Michiue H; Sakurai Y; Kondo N; Kitamatsu M; Bin F; Nakajima K; Hirota Y; Kawabata S; Nishiki T; Ohmori I; Tomizawa K; Miyatake S; Ono K; Matsui H
    Biomaterials; 2014 Mar; 35(10):3396-405. PubMed ID: 24452095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of optically active dodecaborate-containing L-amino acids for BNCT.
    Kusaka S; Hattori Y; Uehara K; Asano T; Tanimori S; Kirihata M
    Appl Radiat Isot; 2011 Dec; 69(12):1768-70. PubMed ID: 21514832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium mercaptoundecahydro-closo-dodecaborate (BSH), a boron carrier that merits more attention.
    Wittig A; Stecher-Rasmussen F; Hilger RA; Rassow J; Mauri P; Sauerwein W
    Appl Radiat Isot; 2011 Dec; 69(12):1760-4. PubMed ID: 21420870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis, and Evaluation of Lipopeptide Conjugates of Mercaptoundecahydrododecaborate for Boron Neutron Capture Therapy.
    Isono A; Tsuji M; Sanada Y; Matsushita A; Masunaga S; Hirayama T; Nagasawa H
    ChemMedChem; 2019 Apr; 14(8):823-832. PubMed ID: 30707500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of boron cluster lipids: closo-dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy.
    Lee JD; Ueno M; Miyajima Y; Nakamura H
    Org Lett; 2007 Jan; 9(2):323-6. PubMed ID: 17217295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
    Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
    Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.
    Masunaga S; Nagasawa H; Gotoh K; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
    Radiat Med; 2006 Feb; 24(2):98-107. PubMed ID: 16715670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
    J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Studies to Define the Cell-Surface and Intracellular Targets of Polyarginine-Conjugated Sodium Borocaptate as a Potential Delivery Agent for Boron Neutron Capture Therapy.
    Fujimura A; Yasui S; Igawa K; Ueda A; Watanabe K; Hanafusa T; Ichikawa Y; Yoshihashi S; Tsuchida K; Kamiya A; Furuya S
    Cells; 2020 Sep; 9(10):. PubMed ID: 32977522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution of (10)B for Boron Neutron Capture Therapy (BNCT) in a mouse model after injection of sodium mercaptoundecahydro-closo-dodecaborate and l-para-boronophenylalanine.
    Wittig A; Huiskamp R; Moss RL; Bet P; Kriegeskotte C; Scherag A; Hilken G; Sauerwein WA
    Radiat Res; 2009 Oct; 172(4):493-9. PubMed ID: 19772470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy.
    Mehta SC; Lai JC; Lu DR
    J Microencapsul; 1996; 13(3):269-79. PubMed ID: 8860683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boron neutron capture therapy: long-term effects on the skin and spinal cord of the rat.
    Morris GM; Constantine G; Ross G; Yeung TK; Hopewell JW
    Radiat Res; 1993 Sep; 135(3):380-6. PubMed ID: 8378531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boron biodistribution for BNCT in the hamster cheek pouch oral cancer model: combined administration of BSH and BPA.
    Garabalino MA; Heber EM; Monti Hughes A; Pozzi EC; Molinari AJ; Nigg DW; Bauer W; Trivillin VA; Schwint AE
    Appl Radiat Isot; 2014 Jun; 88():64-8. PubMed ID: 24360859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Labeled Undecahydro-closo-dodecaborates Based on Azo Dyes for Boron Neutron Capture Therapy: Synthesis, Characterization, and Visualization in Cells.
    Genady AR
    Acta Chim Slov; 2012 Mar; 59(1):89-101. PubMed ID: 24061177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembling A6K peptide nanotubes as a mercaptoundecahydrododecaborate (BSH) delivery system for boron neutron capture therapy (BNCT).
    Michiue H; Kitamatsu M; Fukunaga A; Tsuboi N; Fujimura A; Matsushita H; Igawa K; Kasai T; Kondo N; Matsui H; Furuya S
    J Control Release; 2021 Feb; 330():788-796. PubMed ID: 33188824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of high boron content liposomes and their promising antitumor effect for neutron capture therapy of cancers.
    Koganei H; Ueno M; Tachikawa S; Tasaki L; Ban HS; Suzuki M; Shiraishi K; Kawano K; Yokoyama M; Maitani Y; Ono K; Nakamura H
    Bioconjug Chem; 2013 Jan; 24(1):124-32. PubMed ID: 23214414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell type selective accumulation of mercaptoundecahydro- closo-dodecaborate (BSH) in glioblastoma multiforme.
    Neumann M; Bergmann M; Gabel D
    Acta Neurochir (Wien); 2003 Nov; 145(11):971-5. PubMed ID: 14628202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.